Clinical Trial Update: SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse [Phase 3]

View source ↗

Summary

Phase 3 trial assessing a web-application for detecting relapse in lung cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Weprom | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED